Rank | Gene Set | Z-score |
---|---|---|
1 | sphingoid metabolic process (GO:0046519) | 7.89072051 |
2 | keratinocyte proliferation (GO:0043616) | 6.98994469 |
3 | establishment of skin barrier (GO:0061436) | 6.45456153 |
4 | regulation of ruffle assembly (GO:1900027) | 6.20982745 |
5 | regulation of water loss via skin (GO:0033561) | 6.02928409 |
6 | sphingosine metabolic process (GO:0006670) | 5.63198763 |
7 | diol metabolic process (GO:0034311) | 5.58869345 |
8 | response to peptidoglycan (GO:0032494) | 5.07035498 |
9 | negative regulation of stress fiber assembly (GO:0051497) | 4.89488922 |
10 | gap junction assembly (GO:0016264) | 4.84922847 |
11 | viral transcription (GO:0019083) | 4.70875827 |
12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.70204021 |
13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.70204021 |
14 | modulation by symbiont of host immune response (GO:0052553) | 4.70204021 |
15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.70204021 |
16 | modulation by symbiont of host defense response (GO:0052031) | 4.70204021 |
17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.70204021 |
18 | thymic T cell selection (GO:0045061) | 4.69676546 |
19 | detection of external biotic stimulus (GO:0098581) | 4.69653421 |
20 | keratinocyte differentiation (GO:0030216) | 4.69270972 |
21 | positive thymic T cell selection (GO:0045059) | 4.51164075 |
22 | translational termination (GO:0006415) | 4.49002427 |
23 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.41389128 |
24 | ribosomal small subunit biogenesis (GO:0042274) | 4.40067901 |
25 | keratinization (GO:0031424) | 4.31714599 |
26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.31089626 |
27 | leukocyte aggregation (GO:0070486) | 4.29057111 |
28 | cellular response to interleukin-15 (GO:0071350) | 4.25509503 |
29 | regulation of chemokine secretion (GO:0090196) | 4.24632563 |
30 | macrophage activation involved in immune response (GO:0002281) | 4.23419119 |
31 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.21736483 |
32 | negative regulation of cell killing (GO:0031342) | 4.19840371 |
33 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.19840371 |
34 | lipoxygenase pathway (GO:0019372) | 4.18503427 |
35 | response to muramyl dipeptide (GO:0032495) | 4.15966551 |
36 | neutrophil activation involved in immune response (GO:0002283) | 4.15701634 |
37 | detection of molecule of bacterial origin (GO:0032490) | 4.14243276 |
38 | detection of biotic stimulus (GO:0009595) | 4.11874938 |
39 | heterotypic cell-cell adhesion (GO:0034113) | 4.06423943 |
40 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.02451932 |
41 | positive regulation of chemokine secretion (GO:0090197) | 4.01484159 |
42 | hemidesmosome assembly (GO:0031581) | 3.98057212 |
43 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.97875968 |
44 | regulation of phospholipase A2 activity (GO:0032429) | 3.95164059 |
45 | multicellular organismal water homeostasis (GO:0050891) | 3.94680042 |
46 | T-helper cell differentiation (GO:0042093) | 3.88096569 |
47 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.88096569 |
48 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.85499980 |
49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.82649178 |
50 | interferon-gamma secretion (GO:0072643) | 3.82197847 |
51 | homeostasis of number of cells within a tissue (GO:0048873) | 3.80969803 |
52 | negative regulation of interleukin-12 production (GO:0032695) | 3.79781468 |
53 | T cell selection (GO:0045058) | 3.79096848 |
54 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.76057446 |
55 | germinal center formation (GO:0002467) | 3.74750913 |
56 | positive regulation of interleukin-4 production (GO:0032753) | 3.74054744 |
57 | cellular extravasation (GO:0045123) | 3.73086416 |
58 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.58565012 |
59 | positive T cell selection (GO:0043368) | 3.57680177 |
60 | cellular protein complex disassembly (GO:0043624) | 3.57083710 |
61 | response to interleukin-15 (GO:0070672) | 3.57044708 |
62 | protein targeting to ER (GO:0045047) | 3.55517744 |
63 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.54456090 |
64 | glucosamine-containing compound catabolic process (GO:1901072) | 3.53740319 |
65 | cotranslational protein targeting to membrane (GO:0006613) | 3.53492542 |
66 | translational elongation (GO:0006414) | 3.53252900 |
67 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.50330287 |
68 | T cell migration (GO:0072678) | 3.50163003 |
69 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.49017320 |
70 | T cell receptor signaling pathway (GO:0050852) | 3.48858706 |
71 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.48185957 |
72 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.47804715 |
73 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.47797635 |
74 | epidermal cell differentiation (GO:0009913) | 3.47646057 |
75 | viral life cycle (GO:0019058) | 3.47349271 |
76 | regulation of gamma-delta T cell activation (GO:0046643) | 3.47064297 |
77 | keratinocyte development (GO:0003334) | 3.45786039 |
78 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.44550768 |
79 | barbed-end actin filament capping (GO:0051016) | 3.41264350 |
80 | neutrophil activation (GO:0042119) | 3.40613480 |
81 | granulocyte activation (GO:0036230) | 3.40540569 |
82 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.40532028 |
83 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.40532028 |
84 | T cell differentiation involved in immune response (GO:0002292) | 3.40532028 |
85 | negative regulation of cell fate specification (GO:0009996) | 3.38224982 |
86 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.36752202 |
87 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.35883917 |
88 | negative thymic T cell selection (GO:0045060) | 3.35742287 |
89 | protein localization to endoplasmic reticulum (GO:0070972) | 3.33923058 |
90 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.33473773 |
91 | regulation of interleukin-8 secretion (GO:2000482) | 3.33035407 |
92 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.31813964 |
93 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.30913243 |
94 | negative T cell selection (GO:0043383) | 3.30856429 |
95 | sequestering of actin monomers (GO:0042989) | 3.27956238 |
96 | response to host immune response (GO:0052572) | 3.26838699 |
97 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.26838699 |
98 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.22394095 |
99 | peptide cross-linking (GO:0018149) | 3.22373152 |
100 | water homeostasis (GO:0030104) | 3.22338964 |
101 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.21899443 |
102 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.21596122 |
103 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.19260054 |
104 | molting cycle (GO:0042303) | 3.18072460 |
105 | hair cycle (GO:0042633) | 3.18072460 |
106 | negative regulation of interleukin-8 production (GO:0032717) | 3.17759174 |
107 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.17497155 |
108 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.17403501 |
109 | detection of bacterium (GO:0016045) | 3.15636878 |
110 | ribosomal large subunit biogenesis (GO:0042273) | 3.14600949 |
111 | positive regulation of tolerance induction (GO:0002645) | 3.13058676 |
112 | negative regulation of interleukin-6 production (GO:0032715) | 3.12736649 |
113 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.10040646 |
114 | myeloid cell activation involved in immune response (GO:0002275) | 3.09417447 |
115 | macrophage activation (GO:0042116) | 3.08810977 |
116 | negative regulation of T cell mediated immunity (GO:0002710) | 3.05317963 |
117 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.04898611 |
118 | response to host defenses (GO:0052200) | 3.04877402 |
119 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.04877402 |
120 | response to host (GO:0075136) | 3.04877402 |
121 | interferon-gamma production (GO:0032609) | 3.04626927 |
122 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.03891737 |
123 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.02308233 |
124 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.01536618 |
125 | negative regulation of B cell mediated immunity (GO:0002713) | 3.01536618 |
126 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.01181254 |
127 | fatty acid elongation (GO:0030497) | 3.01077441 |
128 | regulation of mast cell degranulation (GO:0043304) | 3.00946844 |
129 | membrane raft organization (GO:0031579) | 3.00139918 |
130 | epidermis development (GO:0008544) | 2.99888954 |
131 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.98958350 |
132 | regulation of interleukin-4 production (GO:0032673) | 2.98843251 |
133 | regulation of glomerular filtration (GO:0003093) | 2.98745856 |
134 | maturation of SSU-rRNA (GO:0030490) | 2.96762950 |
135 | neutrophil mediated immunity (GO:0002446) | 2.96283966 |
136 | negative regulation of kidney development (GO:0090185) | 2.95750487 |
137 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.94502678 |
138 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.93739058 |
139 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.93315516 |
140 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.92646539 |
141 | regulation of hypersensitivity (GO:0002883) | 2.91818985 |
142 | linoleic acid metabolic process (GO:0043651) | 2.91244240 |
143 | protein complex disassembly (GO:0043241) | 2.90531134 |
144 | respiratory burst (GO:0045730) | 2.90355045 |
145 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.89604192 |
146 | detection of other organism (GO:0098543) | 2.89162398 |
147 | sphingolipid biosynthetic process (GO:0030148) | 2.88923740 |
148 | regulation of leukocyte degranulation (GO:0043300) | 2.88464849 |
149 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.88070521 |
150 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.86163494 |
151 | defense response to protozoan (GO:0042832) | 2.80186055 |
152 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.79657169 |
153 | immunoglobulin mediated immune response (GO:0016064) | 2.78849613 |
154 | regulation of natural killer cell differentiation (GO:0032823) | 2.76842206 |
155 | negative regulation of innate immune response (GO:0045824) | 2.74174099 |
156 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.71697484 |
157 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.70521152 |
158 | microglial cell activation (GO:0001774) | 2.67586932 |
159 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.66362029 |
160 | T-helper 1 type immune response (GO:0042088) | 2.66200180 |
161 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.65347350 |
162 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.63881424 |
163 | cellular response to type I interferon (GO:0071357) | 2.61697438 |
164 | type I interferon signaling pathway (GO:0060337) | 2.61697438 |
165 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.60766658 |
166 | response to type I interferon (GO:0034340) | 2.60555710 |
167 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.59713551 |
168 | leukocyte degranulation (GO:0043299) | 2.59248978 |
169 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.58619156 |
170 | negative regulation of interleukin-17 production (GO:0032700) | 2.58598362 |
171 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.58220209 |
172 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.58220209 |
173 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.57629128 |
174 | regulation of interleukin-6 production (GO:0032675) | 2.56965829 |
175 | NIK/NF-kappaB signaling (GO:0038061) | 2.55858793 |
176 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.55837980 |
177 | desmosome organization (GO:0002934) | 11.6127864 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.83017165 |
2 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 5.06720139 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.98870841 |
4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.42377321 |
5 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 3.03760943 |
6 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.59039905 |
7 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.55524623 |
8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.48455610 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.44504808 |
10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43842707 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.33583182 |
12 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.24555168 |
13 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.22371225 |
14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.19864644 |
15 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.14151362 |
16 | MYC_22102868_ChIP-Seq_BL_Human | 2.14064962 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.02105539 |
18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 14.0658588 |
19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.98560092 |
20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.93281340 |
21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93090288 |
22 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.89497022 |
23 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.86876444 |
24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86560139 |
25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83150179 |
26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.82846198 |
27 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.82815560 |
28 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.80437493 |
29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75935957 |
30 | P68_20966046_ChIP-Seq_HELA_Human | 1.72955062 |
31 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.65413500 |
32 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.65413500 |
33 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.64929751 |
34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64781273 |
35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.63827988 |
36 | MAF_26560356_Chip-Seq_TH1_Human | 1.61115445 |
37 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.60995696 |
38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.57018315 |
39 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.56956444 |
40 | MYB_26560356_Chip-Seq_TH2_Human | 1.54502941 |
41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.50060976 |
42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.49313543 |
43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.49223188 |
44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.48940851 |
45 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.40831222 |
46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.39616962 |
47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.36891942 |
48 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.36029075 |
49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34413289 |
50 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.32527649 |
51 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.32359601 |
52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.32304568 |
53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31766423 |
54 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.29266174 |
55 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.29041441 |
56 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28944616 |
57 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28852339 |
58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.28686601 |
59 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.27730630 |
60 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.27358108 |
61 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25311824 |
62 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.25200889 |
63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25190935 |
64 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.23272016 |
65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22980507 |
66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22557268 |
67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21947820 |
68 | MYB_26560356_Chip-Seq_TH1_Human | 1.21411390 |
69 | SA1_27219007_Chip-Seq_Bcells_Human | 1.21240154 |
70 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.21199986 |
71 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.20805056 |
72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20598396 |
73 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18542455 |
74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17026713 |
75 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.15839208 |
76 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15563486 |
77 | * MAF_26560356_Chip-Seq_TH2_Human | 1.14885326 |
78 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.14014897 |
79 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.13986973 |
80 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.13750730 |
81 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13634747 |
82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13022331 |
83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11927448 |
84 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.11400449 |
85 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.09578851 |
86 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09101047 |
87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08634461 |
88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07815189 |
89 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07164820 |
90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07053188 |
91 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05373456 |
92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05349067 |
93 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04732100 |
94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04546203 |
95 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04124705 |
96 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03131800 |
97 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.02902886 |
98 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02678207 |
99 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00581374 |
100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99614446 |
101 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98385856 |
102 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97508946 |
103 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.95161924 |
104 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.95157592 |
105 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94574436 |
106 | VDR_22108803_ChIP-Seq_LS180_Human | 0.94258270 |
107 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.90739330 |
108 | CJUN_26792858_Chip-Seq_BT549_Human | 0.90188334 |
109 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90187112 |
110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89407784 |
111 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.88621775 |
112 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87692251 |
113 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86641014 |
114 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86584305 |
115 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86332031 |
116 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.85810256 |
117 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.84215862 |
118 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83905480 |
119 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83265444 |
120 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.83089065 |
121 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79317541 |
122 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.78801719 |
123 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.78316094 |
124 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78053429 |
125 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.77867261 |
126 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77696165 |
127 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.77383922 |
128 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77169197 |
129 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.77144452 |
130 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.75556933 |
131 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.75434122 |
132 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.75302560 |
133 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.74214577 |
134 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.74005892 |
135 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.73940955 |
136 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.73899463 |
137 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.73554271 |
138 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.73242555 |
139 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.71293252 |
140 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.71222514 |
141 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.70373316 |
142 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.70221933 |
143 | ATF3_27146783_Chip-Seq_COLON_Human | 0.70141101 |
144 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.69974506 |
145 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.69763983 |
146 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69101548 |
147 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.68747654 |
148 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67998667 |
149 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.67154509 |
150 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.66876940 |
151 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.66876940 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002796_impaired_skin_barrier | 5.10729693 |
2 | MP0003941_abnormal_skin_development | 4.94187079 |
3 | MP0002009_preneoplasia | 4.58769577 |
4 | MP0010234_abnormal_vibrissa_follicle | 3.54233244 |
5 | MP0003303_peritoneal_inflammation | 3.38156154 |
6 | MP0005501_abnormal_skin_physiology | 3.32222717 |
7 | MP0003453_abnormal_keratinocyte_physiol | 3.20641247 |
8 | MP0004381_abnormal_hair_follicle | 3.16411195 |
9 | MP0000566_synostosis | 2.96287683 |
10 | MP0003763_abnormal_thymus_physiology | 2.83440031 |
11 | MP0002166_altered_tumor_susceptibility | 2.79945688 |
12 | MP0002006_tumorigenesis | 2.71991118 |
13 | MP0004947_skin_inflammation | 2.71209806 |
14 | MP0000383_abnormal_hair_follicle | 2.68118038 |
15 | MP0001216_abnormal_epidermal_layer | 2.63862545 |
16 | MP0002254_reproductive_system_inflammat | 2.62688854 |
17 | MP0003191_abnormal_cellular_cholesterol | 2.49498893 |
18 | MP0000685_abnormal_immune_system | 2.46568651 |
19 | MP0002060_abnormal_skin_morphology | 2.46520459 |
20 | MP0005671_abnormal_response_to | 2.41263873 |
21 | MP0000015_abnormal_ear_pigmentation | 2.26780061 |
22 | MP0002098_abnormal_vibrissa_morphology | 2.24670335 |
23 | MP0005275_abnormal_skin_tensile | 2.21867629 |
24 | MP0000467_abnormal_esophagus_morphology | 2.19743863 |
25 | MP0010771_integument_phenotype | 2.14405556 |
26 | MP0000377_abnormal_hair_follicle | 2.08544437 |
27 | MP0009379_abnormal_foot_pigmentation | 2.02948567 |
28 | MP0002234_abnormal_pharynx_morphology | 1.99731741 |
29 | MP0010678_abnormal_skin_adnexa | 1.95075695 |
30 | MP0003300_gastrointestinal_ulcer | 1.86981605 |
31 | MP0010352_gastrointestinal_tract_polyps | 1.84363483 |
32 | MP0005000_abnormal_immune_tolerance | 1.82985764 |
33 | MP0002933_joint_inflammation | 1.76470272 |
34 | MP0000579_abnormal_nail_morphology | 1.75967542 |
35 | MP0003705_abnormal_hypodermis_morpholog | 1.70995429 |
36 | MP0001188_hyperpigmentation | 1.66728161 |
37 | MP0008260_abnormal_autophagy | 1.66566913 |
38 | MP0005451_abnormal_body_composition | 1.66343841 |
39 | MP0009278_abnormal_bone_marrow | 1.65974213 |
40 | MP0001790_abnormal_immune_system | 1.65511209 |
41 | MP0005387_immune_system_phenotype | 1.65511209 |
42 | MP0005409_darkened_coat_color | 1.63719424 |
43 | MP0002405_respiratory_system_inflammati | 1.63186240 |
44 | MP0001800_abnormal_humoral_immune | 1.61170105 |
45 | MP0001835_abnormal_antigen_presentation | 1.57690615 |
46 | MP0003566_abnormal_cell_adhesion | 1.57046652 |
47 | MP0003315_abnormal_perineum_morphology | 1.55243986 |
48 | MP0001243_abnormal_dermal_layer | 1.54149274 |
49 | MP0002723_abnormal_immune_serum | 1.52423988 |
50 | MP0001346_abnormal_lacrimal_gland | 1.52244580 |
51 | MP0009785_altered_susceptibility_to | 1.47750168 |
52 | MP0002148_abnormal_hypersensitivity_rea | 1.47386760 |
53 | MP0001191_abnormal_skin_condition | 1.46780931 |
54 | MP0003436_decreased_susceptibility_to | 1.45800285 |
55 | MP0000647_abnormal_sebaceous_gland | 1.45101737 |
56 | MP0000537_abnormal_urethra_morphology | 1.44627798 |
57 | MP0002420_abnormal_adaptive_immunity | 1.42810776 |
58 | MP0005025_abnormal_response_to | 1.42325116 |
59 | MP0009384_cardiac_valve_regurgitation | 1.41913123 |
60 | MP0001819_abnormal_immune_cell | 1.40420236 |
61 | MP0001851_eye_inflammation | 1.38722330 |
62 | MP0003724_increased_susceptibility_to | 1.35735063 |
63 | MP0009931_abnormal_skin_appearance | 1.35555455 |
64 | MP0003172_abnormal_lysosome_physiology | 1.34683147 |
65 | MP0005171_absent_coat_pigmentation | 1.31513970 |
66 | MP0002452_abnormal_antigen_presenting | 1.30244090 |
67 | MP0005076_abnormal_cell_differentiation | 1.27579955 |
68 | MP0000427_abnormal_hair_cycle | 1.24321274 |
69 | MP0005023_abnormal_wound_healing | 1.22108421 |
70 | MP0005058_abnormal_lysosome_morphology | 1.20843863 |
71 | MP0003011_delayed_dark_adaptation | 1.20197102 |
72 | MP0000465_gastrointestinal_hemorrhage | 1.18351553 |
73 | MP0005464_abnormal_platelet_physiology | 1.18026229 |
74 | MP0010155_abnormal_intestine_physiology | 1.16380166 |
75 | MP0000703_abnormal_thymus_morphology | 1.16228893 |
76 | MP0001986_abnormal_taste_sensitivity | 1.15320206 |
77 | MP0003075_altered_response_to | 1.14953716 |
78 | MP0002998_abnormal_bone_remodeling | 1.14836704 |
79 | MP0005377_hearing/vestibular/ear_phenot | 1.14650503 |
80 | MP0003878_abnormal_ear_physiology | 1.14650503 |
81 | MP0002132_abnormal_respiratory_system | 1.13257065 |
82 | MP0000367_abnormal_coat/_hair | 1.13012491 |
83 | MP0006082_CNS_inflammation | 1.11880358 |
84 | MP0005075_abnormal_melanosome_morpholog | 1.11158416 |
85 | MP0002398_abnormal_bone_marrow | 1.07865834 |
86 | MP0008004_abnormal_stomach_pH | 1.07263380 |
87 | MP0002722_abnormal_immune_system | 1.05758438 |
88 | MP0001853_heart_inflammation | 1.04870631 |
89 | MP0009840_abnormal_foam_cell | 1.04465515 |
90 | MP0009764_decreased_sensitivity_to | 1.03262222 |
91 | MP0000762_abnormal_tongue_morphology | 1.00622066 |
92 | MP0001873_stomach_inflammation | 1.00070442 |
93 | MP0000716_abnormal_immune_system | 0.97437657 |
94 | MP0001545_abnormal_hematopoietic_system | 0.95289416 |
95 | MP0005397_hematopoietic_system_phenotyp | 0.95289416 |
96 | MP0002653_abnormal_ependyma_morphology | 0.92353017 |
97 | MP0000858_altered_metastatic_potential | 0.92288074 |
98 | MP0005174_abnormal_tail_pigmentation | 0.91194263 |
99 | MP0002419_abnormal_innate_immunity | 0.87054432 |
100 | MP0003866_abnormal_defecation | 0.85196189 |
101 | MP0000750_abnormal_muscle_regeneration | 0.83979985 |
102 | MP0008469_abnormal_protein_level | 0.83619466 |
103 | MP0001340_abnormal_eyelid_morphology | 0.83301031 |
104 | MP0001845_abnormal_inflammatory_respons | 0.82957732 |
105 | MP0004130_abnormal_muscle_cell | 0.80946220 |
106 | MP0000627_abnormal_mammary_gland | 0.80870117 |
107 | MP0001984_abnormal_olfaction | 0.80285707 |
108 | MP0002095_abnormal_skin_pigmentation | 0.77888591 |
109 | MP0000689_abnormal_spleen_morphology | 0.74657788 |
110 | MP0003828_pulmonary_edema | 0.73763499 |
111 | MP0004185_abnormal_adipocyte_glucose | 0.71863564 |
112 | MP0005310_abnormal_salivary_gland | 0.71129262 |
113 | MP0002429_abnormal_blood_cell | 0.70255358 |
114 | MP0003448_altered_tumor_morphology | 0.68964724 |
115 | MP0000538_abnormal_urinary_bladder | 0.68411846 |
116 | MP0005390_skeleton_phenotype | 0.67932281 |
117 | MP0002277_abnormal_respiratory_mucosa | 0.65383337 |
118 | MP0003329_amyloid_beta_deposits | 0.65009666 |
119 | MP0002332_abnormal_exercise_endurance | 0.64650274 |
120 | MP0004510_myositis | 0.64604723 |
121 | MP0005166_decreased_susceptibility_to | 0.63127725 |
122 | MP0009333_abnormal_splenocyte_physiolog | 0.61466739 |
123 | MP0000613_abnormal_salivary_gland | 0.59542882 |
124 | MP0010386_abnormal_urinary_bladder | 0.56326994 |
125 | MP0003045_fibrosis | 0.56178457 |
126 | MP0002177_abnormal_outer_ear | 0.55800694 |
127 | MP0001533_abnormal_skeleton_physiology | 0.54652363 |
128 | MP0004782_abnormal_surfactant_physiolog | 0.53699904 |
129 | MP0005623_abnormal_meninges_morphology | 0.49933241 |
130 | MP0000604_amyloidosis | 0.49611906 |
131 | MP0005165_increased_susceptibility_to | 0.49584712 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Lip pit (HP:0100267) | 6.24969728 |
2 | Stomatitis (HP:0010280) | 5.85528861 |
3 | Parakeratosis (HP:0001036) | 5.06053161 |
4 | Woolly hair (HP:0002224) | 4.78675607 |
5 | Hypotrichosis (HP:0001006) | 4.76456163 |
6 | Abnormality of secondary sexual hair (HP:0009888) | 4.44467072 |
7 | Abnormality of the axillary hair (HP:0100134) | 4.44467072 |
8 | Popliteal pterygium (HP:0009756) | 4.31600241 |
9 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.13331189 |
10 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.03395378 |
11 | Thick nail (HP:0001805) | 3.94123444 |
12 | Erythema (HP:0010783) | 3.88031045 |
13 | Conjunctival hamartoma (HP:0100780) | 3.71491322 |
14 | Gangrene (HP:0100758) | 3.69226534 |
15 | Right ventricular cardiomyopathy (HP:0011663) | 3.65667989 |
16 | Autoimmune hemolytic anemia (HP:0001890) | 3.63100386 |
17 | Abnormality of macrophages (HP:0004311) | 3.62815391 |
18 | Pustule (HP:0200039) | 3.62786703 |
19 | Plantar hyperkeratosis (HP:0007556) | 3.56440152 |
20 | Abnormal blistering of the skin (HP:0008066) | 3.33484919 |
21 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.33398088 |
22 | Nasal polyposis (HP:0100582) | 3.28136748 |
23 | Ectropion (HP:0000656) | 3.20863911 |
24 | Alopecia of scalp (HP:0002293) | 3.15887416 |
25 | Increased IgE level (HP:0003212) | 3.13285649 |
26 | Abnormality of the salivary glands (HP:0010286) | 3.11393084 |
27 | Reticulocytopenia (HP:0001896) | 3.09177792 |
28 | Pruritus (HP:0000989) | 3.08593939 |
29 | Hyporeflexia of lower limbs (HP:0002600) | 3.05866730 |
30 | Severe combined immunodeficiency (HP:0004430) | 3.03566951 |
31 | Fragile nails (HP:0001808) | 3.02399594 |
32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.99207264 |
33 | Urticaria (HP:0001025) | 2.97646889 |
34 | Keratoconjunctivitis sicca (HP:0001097) | 2.97284082 |
35 | Palmoplantar hyperkeratosis (HP:0000972) | 2.97282338 |
36 | Gastrointestinal infarctions (HP:0005244) | 2.91894311 |
37 | IgM deficiency (HP:0002850) | 2.91516294 |
38 | Abnormality of T cell physiology (HP:0011840) | 2.91208955 |
39 | Recurrent bronchitis (HP:0002837) | 2.86930279 |
40 | Sparse eyelashes (HP:0000653) | 2.84548270 |
41 | Recurrent sinusitis (HP:0011108) | 2.79667995 |
42 | Eczematoid dermatitis (HP:0000976) | 2.77722332 |
43 | Recurrent abscess formation (HP:0002722) | 2.74963809 |
44 | Corneal erosion (HP:0200020) | 2.74305912 |
45 | Keratoconjunctivitis (HP:0001096) | 2.74146666 |
46 | Milia (HP:0001056) | 2.73752914 |
47 | Abnormal hemoglobin (HP:0011902) | 2.72243715 |
48 | Palmar hyperkeratosis (HP:0010765) | 2.71948161 |
49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.68036519 |
50 | Abnormal number of erythroid precursors (HP:0012131) | 2.65270321 |
51 | Mediastinal lymphadenopathy (HP:0100721) | 2.64015213 |
52 | Petechiae (HP:0000967) | 2.61804848 |
53 | Abnormality of T cells (HP:0002843) | 2.61018355 |
54 | Pili torti (HP:0003777) | 2.60939887 |
55 | Abnormality of the nasal mucosa (HP:0000433) | 2.60416351 |
56 | Hypoplastic labia majora (HP:0000059) | 2.57470286 |
57 | Myositis (HP:0100614) | 2.54150610 |
58 | Combined immunodeficiency (HP:0005387) | 2.53444279 |
59 | Palmoplantar keratoderma (HP:0000982) | 2.49624939 |
60 | Distal lower limb muscle weakness (HP:0009053) | 2.46275812 |
61 | Macrocytic anemia (HP:0001972) | 2.45252658 |
62 | Erythroderma (HP:0001019) | 2.43617725 |
63 | Congenital, generalized hypertrichosis (HP:0004540) | 2.43360850 |
64 | Spontaneous hematomas (HP:0007420) | 2.42889299 |
65 | Onycholysis (HP:0001806) | 2.42264648 |
66 | Abnormality of nail color (HP:0100643) | 2.39585913 |
67 | Abnormal ciliary motility (HP:0012262) | 2.36669452 |
68 | Natal tooth (HP:0000695) | 2.30379893 |
69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.30269321 |
70 | Obstructive lung disease (HP:0006536) | 2.30269321 |
71 | Nail dystrophy (HP:0008404) | 2.29670280 |
72 | Pterygium (HP:0001059) | 2.28296747 |
73 | Abnormality of the labia majora (HP:0012881) | 2.28183907 |
74 | Meningitis (HP:0001287) | 2.27807330 |
75 | Bifid scrotum (HP:0000048) | 2.27141724 |
76 | Double outlet right ventricle (HP:0001719) | 2.26276938 |
77 | Congenital malformation of the right heart (HP:0011723) | 2.26276938 |
78 | Ventricular tachycardia (HP:0004756) | 2.24739124 |
79 | Abnormality of glycolipid metabolism (HP:0010969) | 2.24211149 |
80 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.24211149 |
81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.24211149 |
82 | Gingivitis (HP:0000230) | 2.23856358 |
83 | Hypoplasia of the uterus (HP:0000013) | 2.22429552 |
84 | Hamartoma of the eye (HP:0010568) | 2.22194337 |
85 | Increased IgM level (HP:0003496) | 2.20077855 |
86 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.19807456 |
87 | Hypohidrosis (HP:0000966) | 2.16741621 |
88 | Fragile skin (HP:0001030) | 2.15692875 |
89 | Advanced eruption of teeth (HP:0006288) | 2.14625723 |
90 | Recurrent skin infections (HP:0001581) | 2.14590826 |
91 | Oral leukoplakia (HP:0002745) | 2.14365696 |
92 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.11578387 |
93 | Recurrent cutaneous fungal infections (HP:0011370) | 2.11578387 |
94 | Pallor (HP:0000980) | 2.11300888 |
95 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.08429686 |
96 | Paralysis (HP:0003470) | 2.07632543 |
97 | Cellulitis (HP:0100658) | 2.06685830 |
98 | Asplenia (HP:0001746) | 2.06549132 |
99 | Bronchiectasis (HP:0002110) | 2.06033965 |
100 | Sparse scalp hair (HP:0002209) | 2.05538633 |
101 | T lymphocytopenia (HP:0005403) | 2.04699787 |
102 | Orchitis (HP:0100796) | 2.04041189 |
103 | Thin bony cortex (HP:0002753) | 2.03486115 |
104 | Abnormal hair laboratory examination (HP:0003328) | 2.02845449 |
105 | Testicular atrophy (HP:0000029) | 2.02290326 |
106 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.01911031 |
107 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.01911031 |
108 | IgG deficiency (HP:0004315) | 2.01252649 |
109 | Retrobulbar optic neuritis (HP:0100654) | 2.01227057 |
110 | Optic neuritis (HP:0100653) | 2.01227057 |
111 | Ulnar claw (HP:0001178) | 2.01132777 |
112 | Vasculitis (HP:0002633) | 2.01079986 |
113 | Hematochezia (HP:0002573) | 1.99380285 |
114 | Amyloidosis (HP:0011034) | 1.98859379 |
115 | Hypoparathyroidism (HP:0000829) | 1.98816635 |
116 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.97531245 |
117 | Hypergammaglobulinemia (HP:0010702) | 1.97443388 |
118 | Recurrent fungal infections (HP:0002841) | 1.95917867 |
119 | Chronic diarrhea (HP:0002028) | 1.95293951 |
120 | Recurrent bacterial skin infections (HP:0005406) | 1.95006790 |
121 | Sepsis (HP:0100806) | 1.94853235 |
122 | Hemoptysis (HP:0002105) | 1.93914315 |
123 | Skin ulcer (HP:0200042) | 1.93744665 |
124 | Prolonged bleeding time (HP:0003010) | 1.93534520 |
125 | Prostate neoplasm (HP:0100787) | 1.93319664 |
126 | Unilateral renal agenesis (HP:0000122) | 1.93205870 |
127 | Dry skin (HP:0000958) | 1.92196490 |
128 | Hypoalbuminemia (HP:0003073) | 1.92150107 |
129 | Abnormal albumin level (HP:0012116) | 1.92150107 |
130 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.91548190 |
131 | Hypochromic anemia (HP:0001931) | 1.90889082 |
132 | Anorexia (HP:0002039) | 1.90070797 |
133 | Xerostomia (HP:0000217) | 1.88981125 |
134 | Abnormality of the costochondral junction (HP:0000919) | 1.87251511 |
135 | Encephalitis (HP:0002383) | 1.86416771 |
136 | Abnormality of the fingertips (HP:0001211) | 1.86110373 |
137 | Chest pain (HP:0100749) | 1.83715680 |
138 | Episodic fever (HP:0001954) | 1.81158104 |
139 | Hemorrhage of the eye (HP:0011885) | 1.78012963 |
140 | Epistaxis (HP:0000421) | 1.76525936 |
141 | Verrucae (HP:0200043) | 1.75760189 |
142 | Papilloma (HP:0012740) | 1.75760189 |
143 | Hypermelanotic macule (HP:0001034) | 1.74932616 |
144 | Malnutrition (HP:0004395) | 1.73952252 |
145 | Peritonitis (HP:0002586) | 1.73410625 |
146 | Loss of speech (HP:0002371) | 1.71391018 |
147 | Increased cerebral lipofuscin (HP:0011813) | 1.71294504 |
148 | Pulmonary infiltrates (HP:0002113) | 1.71038061 |
149 | Cheilitis (HP:0100825) | 1.70093134 |
150 | Arterial thrombosis (HP:0004420) | 1.69528136 |
151 | Annular pancreas (HP:0001734) | 1.65006312 |
152 | Difficulty running (HP:0009046) | 1.64680856 |
153 | Melanocytic nevus (HP:0000995) | 1.63794521 |
154 | Hepatosplenomegaly (HP:0001433) | 1.63719572 |
155 | Inflammation of the large intestine (HP:0002037) | 1.63349800 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TESK1 | 4.29909102 |
2 | MST4 | 4.15598415 |
3 | MAP4K1 | 3.90224715 |
4 | TESK2 | 3.43778294 |
5 | LIMK1 | 3.33057083 |
6 | PRPF4B | 3.08223330 |
7 | ERN1 | 3.03738165 |
8 | IRAK4 | 2.99271922 |
9 | KDR | 2.96938791 |
10 | TRPM7 | 2.93523150 |
11 | MAP3K12 | 2.91469745 |
12 | TXK | 2.69851976 |
13 | MAPKAPK3 | 2.67429949 |
14 | TNK2 | 2.60820292 |
15 | ZAP70 | 2.48484191 |
16 | TAOK1 | 2.17324932 |
17 | ITK | 2.15515677 |
18 | EPHB2 | 1.89302089 |
19 | RIPK4 | 1.88349397 |
20 | IRAK2 | 1.87051356 |
21 | STK10 | 1.81525040 |
22 | FER | 1.77644317 |
23 | LCK | 1.66748391 |
24 | MAP3K3 | 1.66030894 |
25 | TRIB3 | 1.60375813 |
26 | MARK2 | 1.59873292 |
27 | BLK | 1.59749210 |
28 | MAP2K6 | 1.53126428 |
29 | MAP3K11 | 1.48099628 |
30 | SIK3 | 1.47154718 |
31 | TAOK2 | 1.41601888 |
32 | LRRK2 | 1.37808139 |
33 | PRKD2 | 1.35107397 |
34 | IRAK1 | 1.32201985 |
35 | FES | 1.32058303 |
36 | MAP3K14 | 1.28722477 |
37 | PIM2 | 1.27940163 |
38 | FGFR1 | 1.26916726 |
39 | EIF2AK1 | 1.25845922 |
40 | JAK1 | 1.24272055 |
41 | MAP3K2 | 1.21137558 |
42 | IRAK3 | 1.18842581 |
43 | RPS6KB2 | 1.17809157 |
44 | IKBKE | 1.17450298 |
45 | RIPK1 | 1.17376991 |
46 | KSR2 | 1.14265743 |
47 | ERBB3 | 1.13552462 |
48 | SIK1 | 1.13451282 |
49 | SIK2 | 1.08691303 |
50 | PDGFRB | 1.06393422 |
51 | EIF2AK3 | 1.06237051 |
52 | FGFR4 | 1.04878834 |
53 | MAP3K13 | 1.04309349 |
54 | TEC | 1.03484800 |
55 | CSK | 1.00653052 |
56 | FGR | 0.99930035 |
57 | SMG1 | 0.99219484 |
58 | SYK | 0.98839805 |
59 | STK24 | 0.95755339 |
60 | MAP3K7 | 0.93350480 |
61 | MAPK15 | 0.91278653 |
62 | JAK3 | 0.91270202 |
63 | MARK3 | 0.88691747 |
64 | MST1R | 0.87865190 |
65 | PRKCQ | 0.87785271 |
66 | PIK3CG | 0.87410036 |
67 | MAP3K6 | 0.86355732 |
68 | MAP2K4 | 0.85007210 |
69 | ICK | 0.84508175 |
70 | MAPK7 | 0.84279381 |
71 | TYK2 | 0.83930340 |
72 | IKBKB | 0.82514177 |
73 | HCK | 0.82400378 |
74 | PDPK1 | 0.78673068 |
75 | CDK12 | 0.76777246 |
76 | CDC42BPA | 0.76603904 |
77 | MATK | 0.75071841 |
78 | PDK2 | 0.73807386 |
79 | BTK | 0.72808749 |
80 | MYLK | 0.72032607 |
81 | KIT | 0.68797551 |
82 | SGK3 | 0.66626427 |
83 | TTN | 0.64413518 |
84 | EPHB1 | 0.64342776 |
85 | HIPK2 | 0.64164213 |
86 | ROCK2 | 0.64056945 |
87 | FYN | 0.62837567 |
88 | DYRK3 | 0.62386977 |
89 | GRK7 | 0.62077459 |
90 | GRK6 | 0.61422378 |
91 | RPS6KC1 | 0.61410328 |
92 | RPS6KL1 | 0.61410328 |
93 | LYN | 0.59916011 |
94 | MAPKAPK5 | 0.59770756 |
95 | EEF2K | 0.57419549 |
96 | EIF2AK2 | 0.55312229 |
97 | SCYL2 | 0.55228444 |
98 | DYRK1B | 0.54657928 |
99 | CLK1 | 0.53951182 |
100 | ABL1 | 0.53917947 |
101 | BMX | 0.53692518 |
102 | PTK2 | 0.53605175 |
103 | EPHA3 | 0.53395936 |
104 | MAP3K1 | 0.53075761 |
105 | PTK6 | 0.52945860 |
106 | TGFBR1 | 0.52662747 |
107 | PDK1 | 0.51710481 |
108 | TBK1 | 0.51399944 |
109 | SGK494 | 0.51144526 |
110 | SGK223 | 0.51144526 |
111 | RPS6KA2 | 0.50792637 |
112 | RPS6KA6 | 0.50128796 |
113 | MAPK12 | 0.49323255 |
114 | MAP3K5 | 0.48769822 |
115 | WNK1 | 0.48138491 |
116 | TAOK3 | 0.47816798 |
117 | ROCK1 | 0.47262141 |
118 | GRK1 | 0.46481699 |
119 | STK11 | 0.46440186 |
120 | SRC | 0.46436474 |
121 | MOS | 0.44811415 |
122 | MAP2K3 | 0.44288634 |
123 | PRKD1 | 0.44266354 |
124 | AURKA | 0.43765674 |
125 | MAPK11 | 0.41844251 |
126 | FGFR2 | 0.41660049 |
127 | INSR | 0.41457754 |
128 | STK4 | 0.41411486 |
129 | YES1 | 0.41101140 |
130 | RPS6KA1 | 0.39876231 |
131 | NTRK2 | 0.39663953 |
132 | SGK2 | 0.38640747 |
133 | CAMK4 | 0.38475841 |
134 | RAF1 | 0.38394100 |
135 | JAK2 | 0.37768018 |
136 | STK39 | 0.35782117 |
137 | TLK1 | 0.33520639 |
138 | TGFBR2 | 0.33295482 |
139 | RPS6KA4 | 0.32396177 |
140 | MAPKAPK2 | 0.32262224 |
141 | ILK | 0.31699989 |
142 | BCR | 0.31303200 |
143 | EPHA2 | 0.29889235 |
144 | CDK9 | 0.29162310 |
145 | ERBB4 | 0.27827368 |
146 | PRKCD | 0.27554635 |
147 | TNIK | 0.26572202 |
148 | FGFR3 | 0.25934946 |
149 | DAPK3 | 0.25759023 |
150 | PRKCH | 0.24689960 |
151 | CHUK | 0.24678023 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.52361765 |
2 | Ribosome_Homo sapiens_hsa03010 | 3.95066997 |
3 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 3.34939097 |
4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.23555344 |
5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.01995330 |
6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.86538459 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.32261063 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.19936695 |
9 | Allograft rejection_Homo sapiens_hsa05330 | 2.05303616 |
10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.98489443 |
11 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.95508501 |
12 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.94168351 |
13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.80565015 |
14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.76311838 |
15 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.70232779 |
16 | Viral myocarditis_Homo sapiens_hsa05416 | 1.64431500 |
17 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.64265333 |
18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.63036305 |
19 | Malaria_Homo sapiens_hsa05144 | 1.61786990 |
20 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.60612864 |
21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.57118353 |
22 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.55458558 |
23 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.51291377 |
24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.50891312 |
25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.46590111 |
26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.45820716 |
27 | Measles_Homo sapiens_hsa05162 | 1.45512131 |
28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.45374085 |
29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.44499183 |
30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.44318275 |
31 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.39283955 |
32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38494776 |
33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38414979 |
34 | Influenza A_Homo sapiens_hsa05164 | 1.36042901 |
35 | Lysosome_Homo sapiens_hsa04142 | 1.29209925 |
36 | Pertussis_Homo sapiens_hsa05133 | 1.27522742 |
37 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.21776117 |
38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.19050775 |
39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18879111 |
40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.17646036 |
41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.17049040 |
42 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.17017144 |
43 | Shigellosis_Homo sapiens_hsa05131 | 1.16162811 |
44 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.14086219 |
45 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.12819236 |
46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11883600 |
47 | Salmonella infection_Homo sapiens_hsa05132 | 1.11281546 |
48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.10374242 |
49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.09395950 |
50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.07804533 |
51 | Hepatitis B_Homo sapiens_hsa05161 | 1.05676987 |
52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02912752 |
53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99475806 |
54 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99059196 |
55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98656260 |
56 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.97435797 |
57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.97014577 |
58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96861802 |
59 | Phagosome_Homo sapiens_hsa04145 | 0.96691901 |
60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93432460 |
61 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92312945 |
62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92189878 |
63 | Bladder cancer_Homo sapiens_hsa05219 | 0.91503574 |
64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88427247 |
65 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.86247416 |
66 | Apoptosis_Homo sapiens_hsa04210 | 0.86152349 |
67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85593934 |
68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84102663 |
69 | Asthma_Homo sapiens_hsa05310 | 0.83556298 |
70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82928897 |
71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81733444 |
72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81066712 |
73 | Legionellosis_Homo sapiens_hsa05134 | 0.80782028 |
74 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.80013597 |
75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.79845139 |
76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78881581 |
77 | Adherens junction_Homo sapiens_hsa04520 | 0.77480745 |
78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.76086473 |
79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74012028 |
80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73150365 |
81 | Tuberculosis_Homo sapiens_hsa05152 | 0.72066966 |
82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71794768 |
83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69808964 |
84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68994257 |
85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.68701320 |
86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68147674 |
87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67327293 |
88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66933882 |
89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66688280 |
90 | Glioma_Homo sapiens_hsa05214 | 0.66293997 |
91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65613298 |
92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64129499 |
93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63932535 |
94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63597927 |
95 | Axon guidance_Homo sapiens_hsa04360 | 0.63550921 |
96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62900396 |
97 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62296903 |
98 | Platelet activation_Homo sapiens_hsa04611 | 0.60623520 |
99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.58906014 |
100 | Insulin resistance_Homo sapiens_hsa04931 | 0.57819560 |
101 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57386303 |
102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55350163 |
103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54857333 |
104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53124909 |
105 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52859350 |
106 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52757817 |
107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51930833 |
108 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51902862 |
109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51173841 |
110 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50254868 |
111 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50158867 |
112 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49365171 |
113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49089300 |
114 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48959948 |
115 | Endocytosis_Homo sapiens_hsa04144 | 0.48609983 |
116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48537382 |
117 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47202382 |
118 | Long-term depression_Homo sapiens_hsa04730 | 0.47151715 |
119 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46050142 |
120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45972983 |
121 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45889359 |
122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43124126 |
123 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40857796 |
124 | Renin secretion_Homo sapiens_hsa04924 | 0.38377312 |
125 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37255924 |
126 | Amoebiasis_Homo sapiens_hsa05146 | 0.36146622 |
127 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35619608 |
128 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.35451327 |
129 | ABC transporters_Homo sapiens_hsa02010 | 0.32138168 |
130 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.31814246 |
131 | Hepatitis C_Homo sapiens_hsa05160 | 0.31716609 |
132 | Mineral absorption_Homo sapiens_hsa04978 | 0.31000596 |
133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30947243 |
134 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.30081175 |
135 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.30049110 |
136 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.29819307 |
137 | Tight junction_Homo sapiens_hsa04530 | 0.29564157 |
138 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.29480035 |
139 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29347976 |
140 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.28407418 |
141 | Protein export_Homo sapiens_hsa03060 | 0.28311008 |